Analyst price target range
Silence Therapeutics Price Target: $33.00 Average
Direct answer
Silence Therapeutics's average price target is $33.00.
The verified analyst range runs from $10.00 to $75.00.
The low target implies -18.4%, the high target implies +512.2%, and the range spans 530.6% of the current price.
Forecast evidence checked September 22, 2026.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $12.25
- Average price target
- $33.00
- High price target
- $75.00
- Low price target
- $10.00
- Low target gap
- -18.4%
- Target upside
- +169.4%
- High target gap
- +512.2%
- Target range width
- 530.6%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- September 22, 2026
- Valid through
- September 29, 2026
Explore related company data
Read the frequently asked questions.
What is Silence Therapeutics's average price target?
Silence Therapeutics's verified average price target is $33.00. The target range is $10.00 to $75.00.
How far are Silence Therapeutics's low and high targets from the recorded price?
The low target implies -18.4%, while the high target implies +512.2%.
How many analysts are included in Silence Therapeutics's consensus?
The verified consensus includes 6 analysts.
How is Silence Therapeutics's target upside or downside calculated?
The average target of $33.00 is divided by the recorded price of $12.25, then one is subtracted to produce +169.4%. This does not guarantee a future return.
When was Silence Therapeutics's analyst forecast verified?
The data was verified on 2026-09-22. The dataset is valid through 2026-09-29.